Legal Opinion

Fibrogen, Inc. v. Hangzhou Andao Pharmaceutical LTD.

District Court, N.D. California

Decided March 20, 2024No. 4:22-cv-07148Unknown

1Opinion

1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 7 FIBROGEN, INC., Case No. 22-cv-07148-AMO 8 Plaintiff, ORDER GRANTING IN PART AND 9 v. DENYING IN PART MOTION TO DISMISS 10 HANGZHOU ANDAO PHARMACEUTICAL LTD., et al., Re: Dkt. Nos. 31, 78, 105 11 Defendants. 12 13 This case is about former employees’ use of an employer’s intellectual property. 14 Defendants Hangzhou Andao Pharmaceutical Ltd., Kind Pharmaceuticals LLC, Dr. Dong Liu, and 15 Dr. Shaojiang Deng’s motion to dismiss was heard before this Court on August 17, 2023. Also 16 pending before the Court is…

2Cases cited26 opinions

  1. Ashcroft v. IqbalSupreme Court of the United States · 2009
  2. Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
  3. Bartlett v. StricklandSupreme Court of the United States · 2009
  4. In Re Gilead Sciences Securities LitigationCourt of Appeals for the Ninth Circuit · 2008
  5. Mendiondo v. Centinela Hospital Medical CenterCourt of Appeals for the Ninth Circuit · 2008

21 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API